Regor Therapeutics

Regor Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing clinically differentiated innovative drugs through its proprietary rCARD™ (Computational Acceleration of Research and Development) platform. The company concentrates on three major therapeutic areas: oncology, immunology, and metabolic diseases. Regor Therapeutics has successfully built a world-class scientific research and development team. By deeply integrating the rCARD™ platform with structural biology, computational chemistry, computational biology, biology, medicinal chemistry, and clinical development, the company has established an efficient new drug innovation engine to discover and develop globally innovative (first-in-class) and best-in-class molecules with independent intellectual property rights.